nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—migraine—Prednisone—ulcerative colitis	0.582	1	CpDpCtD
Ergotamine—ABCB1—ulcerative colitis	0.165	1	CbGaD
Ergotamine—CYP3A4—Budesonide—ulcerative colitis	0.0216	0.131	CbGbCtD
Ergotamine—CYP1A2—Nicotine—ulcerative colitis	0.0179	0.109	CbGbCtD
Ergotamine—ABCB1—Methylprednisolone—ulcerative colitis	0.0161	0.0978	CbGbCtD
Ergotamine—ABCB1—Betamethasone—ulcerative colitis	0.0105	0.0636	CbGbCtD
Ergotamine—ABCB1—Prednisolone—ulcerative colitis	0.0103	0.0627	CbGbCtD
Ergotamine—ABCB1—Hydrocortisone—ulcerative colitis	0.00978	0.0595	CbGbCtD
Ergotamine—ABCB1—Prednisone—ulcerative colitis	0.00974	0.0592	CbGbCtD
Ergotamine—CYP3A4—Methylprednisolone—ulcerative colitis	0.00963	0.0586	CbGbCtD
Ergotamine—CYP3A4—Nicotine—ulcerative colitis	0.00939	0.0571	CbGbCtD
Ergotamine—CYP3A4—Cholecalciferol—ulcerative colitis	0.00842	0.0512	CbGbCtD
Ergotamine—CYP3A4—Triamcinolone—ulcerative colitis	0.0073	0.0444	CbGbCtD
Ergotamine—CYP3A4—Betamethasone—ulcerative colitis	0.00626	0.0381	CbGbCtD
Ergotamine—CYP3A4—Prednisolone—ulcerative colitis	0.00618	0.0376	CbGbCtD
Ergotamine—ABCB1—Dexamethasone—ulcerative colitis	0.00608	0.037	CbGbCtD
Ergotamine—CYP3A4—Hydrocortisone—ulcerative colitis	0.00586	0.0356	CbGbCtD
Ergotamine—CYP3A4—Prednisone—ulcerative colitis	0.00584	0.0355	CbGbCtD
Ergotamine—CYP3A4—Dexamethasone—ulcerative colitis	0.00364	0.0222	CbGbCtD
Ergotamine—Numbness—Nicotine—ulcerative colitis	0.001	0.0573	CcSEcCtD
Ergotamine—Sensory loss—Nicotine—ulcerative colitis	0.000961	0.0548	CcSEcCtD
Ergotamine—HTR2A—enteric nervous system—ulcerative colitis	0.000821	0.323	CbGeAlD
Ergotamine—HTR2A—myenteric nerve plexus—ulcerative colitis	0.000622	0.245	CbGeAlD
Ergotamine—Dihydroergotamine—ABCB1—ulcerative colitis	0.000426	0.415	CrCbGaD
Ergotamine—Hypoaesthesia—Nicotine—ulcerative colitis	0.000416	0.0237	CcSEcCtD
Ergotamine—Ergonovine—ABCB1—ulcerative colitis	0.00039	0.379	CrCbGaD
Ergotamine—Vertigo—Nicotine—ulcerative colitis	0.000327	0.0187	CcSEcCtD
Ergotamine—Hypertension—Nicotine—ulcerative colitis	0.000314	0.0179	CcSEcCtD
Ergotamine—Myalgia—Nicotine—ulcerative colitis	0.00031	0.0177	CcSEcCtD
Ergotamine—Tachycardia—Nicotine—ulcerative colitis	0.00029	0.0165	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Mercaptopurine—ulcerative colitis	0.000279	0.0159	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Nicotine—ulcerative colitis	0.000271	0.0154	CcSEcCtD
Ergotamine—Paraesthesia—Nicotine—ulcerative colitis	0.000267	0.0152	CcSEcCtD
Ergotamine—Pain—Nicotine—ulcerative colitis	0.000254	0.0145	CcSEcCtD
Ergotamine—Vertigo—Budesonide—ulcerative colitis	0.000225	0.0128	CcSEcCtD
Ergotamine—Hypertension—Budesonide—ulcerative colitis	0.000216	0.0123	CcSEcCtD
Ergotamine—Myalgia—Budesonide—ulcerative colitis	0.000213	0.0122	CcSEcCtD
Ergotamine—Asthenia—Nicotine—ulcerative colitis	0.000213	0.0122	CcSEcCtD
Ergotamine—Bromocriptine—ABCB1—ulcerative colitis	0.000212	0.206	CrCbGaD
Ergotamine—Pruritus—Nicotine—ulcerative colitis	0.00021	0.012	CcSEcCtD
Ergotamine—Tachycardia—Budesonide—ulcerative colitis	0.0002	0.0114	CcSEcCtD
Ergotamine—Vomiting—Mercaptopurine—ulcerative colitis	0.000195	0.0111	CcSEcCtD
Ergotamine—Myalgia—Azathioprine—ulcerative colitis	0.000191	0.0109	CcSEcCtD
Ergotamine—Vomiting—Nicotine—ulcerative colitis	0.000189	0.0108	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Budesonide—ulcerative colitis	0.000186	0.0106	CcSEcCtD
Ergotamine—Paraesthesia—Budesonide—ulcerative colitis	0.000184	0.0105	CcSEcCtD
Ergotamine—Vertigo—Mesalazine—ulcerative colitis	0.000183	0.0104	CcSEcCtD
Ergotamine—Nausea—Mercaptopurine—ulcerative colitis	0.000182	0.0104	CcSEcCtD
Ergotamine—Nausea—Nicotine—ulcerative colitis	0.000176	0.0101	CcSEcCtD
Ergotamine—Hypertension—Mesalazine—ulcerative colitis	0.000176	0.01	CcSEcCtD
Ergotamine—Pain—Budesonide—ulcerative colitis	0.000175	0.00998	CcSEcCtD
Ergotamine—Bradycardia—Prednisolone—ulcerative colitis	0.000174	0.0099	CcSEcCtD
Ergotamine—Myalgia—Mesalazine—ulcerative colitis	0.000174	0.0099	CcSEcCtD
Ergotamine—Bradycardia—Hydrocortisone—ulcerative colitis	0.00017	0.00967	CcSEcCtD
Ergotamine—ADRA1D—epithelium—ulcerative colitis	0.000167	0.0655	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000166	0.00949	CcSEcCtD
Ergotamine—Tachycardia—Mesalazine—ulcerative colitis	0.000162	0.00926	CcSEcCtD
Ergotamine—Bradycardia—Triamcinolone—ulcerative colitis	0.00016	0.00911	CcSEcCtD
Ergotamine—Bradycardia—Methylprednisolone—ulcerative colitis	0.000159	0.00909	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000152	0.00865	CcSEcCtD
Ergotamine—Paraesthesia—Mesalazine—ulcerative colitis	0.000149	0.00852	CcSEcCtD
Ergotamine—Asthenia—Budesonide—ulcerative colitis	0.000147	0.00837	CcSEcCtD
Ergotamine—Bradycardia—Betamethasone—ulcerative colitis	0.000145	0.00826	CcSEcCtD
Ergotamine—Bradycardia—Dexamethasone—ulcerative colitis	0.000145	0.00826	CcSEcCtD
Ergotamine—Pruritus—Budesonide—ulcerative colitis	0.000145	0.00826	CcSEcCtD
Ergotamine—Pain—Mesalazine—ulcerative colitis	0.000142	0.00812	CcSEcCtD
Ergotamine—Vertigo—Prednisolone—ulcerative colitis	0.000133	0.00761	CcSEcCtD
Ergotamine—Vertigo—Hydrocortisone—ulcerative colitis	0.00013	0.00743	CcSEcCtD
Ergotamine—Vomiting—Budesonide—ulcerative colitis	0.00013	0.00742	CcSEcCtD
Ergotamine—Hypertension—Prednisolone—ulcerative colitis	0.000128	0.00731	CcSEcCtD
Ergotamine—Bradycardia—Prednisone—ulcerative colitis	0.000126	0.0072	CcSEcCtD
Ergotamine—Hypertension—Hydrocortisone—ulcerative colitis	0.000125	0.00714	CcSEcCtD
Ergotamine—Myalgia—Hydrocortisone—ulcerative colitis	0.000123	0.00704	CcSEcCtD
Ergotamine—Vertigo—Triamcinolone—ulcerative colitis	0.000123	0.007	CcSEcCtD
Ergotamine—Vertigo—Methylprednisolone—ulcerative colitis	0.000122	0.00698	CcSEcCtD
Ergotamine—Nausea—Budesonide—ulcerative colitis	0.000122	0.00693	CcSEcCtD
Ergotamine—Asthenia—Mesalazine—ulcerative colitis	0.000119	0.00681	CcSEcCtD
Ergotamine—Tachycardia—Prednisolone—ulcerative colitis	0.000118	0.00675	CcSEcCtD
Ergotamine—Hypertension—Triamcinolone—ulcerative colitis	0.000118	0.00672	CcSEcCtD
Ergotamine—Pruritus—Mesalazine—ulcerative colitis	0.000118	0.00672	CcSEcCtD
Ergotamine—Hypertension—Methylprednisolone—ulcerative colitis	0.000118	0.00671	CcSEcCtD
Ergotamine—Myalgia—Triamcinolone—ulcerative colitis	0.000116	0.00663	CcSEcCtD
Ergotamine—Vomiting—Azathioprine—ulcerative colitis	0.000116	0.00663	CcSEcCtD
Ergotamine—Myalgia—Methylprednisolone—ulcerative colitis	0.000116	0.00662	CcSEcCtD
Ergotamine—Tachycardia—Hydrocortisone—ulcerative colitis	0.000115	0.00659	CcSEcCtD
Ergotamine—HTR2B—smooth muscle tissue—ulcerative colitis	0.000112	0.0439	CbGeAlD
Ergotamine—Vertigo—Dexamethasone—ulcerative colitis	0.000111	0.00635	CcSEcCtD
Ergotamine—Vertigo—Betamethasone—ulcerative colitis	0.000111	0.00635	CcSEcCtD
Ergotamine—Paraesthesia—Prednisolone—ulcerative colitis	0.000109	0.00621	CcSEcCtD
Ergotamine—Tachycardia—Triamcinolone—ulcerative colitis	0.000109	0.0062	CcSEcCtD
Ergotamine—Nausea—Azathioprine—ulcerative colitis	0.000109	0.00619	CcSEcCtD
Ergotamine—Tachycardia—Methylprednisolone—ulcerative colitis	0.000108	0.00619	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000108	0.00615	CcSEcCtD
Ergotamine—Hypertension—Dexamethasone—ulcerative colitis	0.000107	0.0061	CcSEcCtD
Ergotamine—Hypertension—Betamethasone—ulcerative colitis	0.000107	0.0061	CcSEcCtD
Ergotamine—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000106	0.00606	CcSEcCtD
Ergotamine—Vomiting—Mesalazine—ulcerative colitis	0.000106	0.00604	CcSEcCtD
Ergotamine—Myalgia—Dexamethasone—ulcerative colitis	0.000105	0.00602	CcSEcCtD
Ergotamine—Myalgia—Betamethasone—ulcerative colitis	0.000105	0.00602	CcSEcCtD
Ergotamine—Pain—Prednisolone—ulcerative colitis	0.000104	0.00591	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000102	0.00579	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000101	0.00578	CcSEcCtD
Ergotamine—Pain—Hydrocortisone—ulcerative colitis	0.000101	0.00577	CcSEcCtD
Ergotamine—Paraesthesia—Triamcinolone—ulcerative colitis	0.0001	0.00571	CcSEcCtD
Ergotamine—Paraesthesia—Methylprednisolone—ulcerative colitis	9.98e-05	0.00569	CcSEcCtD
Ergotamine—Nausea—Mesalazine—ulcerative colitis	9.88e-05	0.00564	CcSEcCtD
Ergotamine—Tachycardia—Dexamethasone—ulcerative colitis	9.87e-05	0.00563	CcSEcCtD
Ergotamine—Tachycardia—Betamethasone—ulcerative colitis	9.87e-05	0.00563	CcSEcCtD
Ergotamine—Vertigo—Prednisone—ulcerative colitis	9.69e-05	0.00553	CcSEcCtD
Ergotamine—ADRA1A—epithelium—ulcerative colitis	9.58e-05	0.0376	CbGeAlD
Ergotamine—Pain—Triamcinolone—ulcerative colitis	9.53e-05	0.00544	CcSEcCtD
Ergotamine—Hypertension—Prednisone—ulcerative colitis	9.31e-05	0.00531	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	9.21e-05	0.00525	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	9.21e-05	0.00525	CcSEcCtD
Ergotamine—Myalgia—Prednisone—ulcerative colitis	9.18e-05	0.00524	CcSEcCtD
Ergotamine—Paraesthesia—Dexamethasone—ulcerative colitis	9.08e-05	0.00518	CcSEcCtD
Ergotamine—Paraesthesia—Betamethasone—ulcerative colitis	9.08e-05	0.00518	CcSEcCtD
Ergotamine—HTR2B—digestive system—ulcerative colitis	8.82e-05	0.0347	CbGeAlD
Ergotamine—Pain—Dexamethasone—ulcerative colitis	8.64e-05	0.00493	CcSEcCtD
Ergotamine—Pain—Betamethasone—ulcerative colitis	8.64e-05	0.00493	CcSEcCtD
Ergotamine—Tachycardia—Prednisone—ulcerative colitis	8.59e-05	0.0049	CcSEcCtD
Ergotamine—Asthenia—Hydrocortisone—ulcerative colitis	8.49e-05	0.00484	CcSEcCtD
Ergotamine—Pruritus—Hydrocortisone—ulcerative colitis	8.37e-05	0.00478	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	8.02e-05	0.00458	CcSEcCtD
Ergotamine—Asthenia—Triamcinolone—ulcerative colitis	7.99e-05	0.00456	CcSEcCtD
Ergotamine—Asthenia—Methylprednisolone—ulcerative colitis	7.98e-05	0.00455	CcSEcCtD
Ergotamine—Paraesthesia—Prednisone—ulcerative colitis	7.9e-05	0.00451	CcSEcCtD
Ergotamine—Pruritus—Triamcinolone—ulcerative colitis	7.88e-05	0.0045	CcSEcCtD
Ergotamine—Pruritus—Methylprednisolone—ulcerative colitis	7.86e-05	0.00449	CcSEcCtD
Ergotamine—Vomiting—Hydrocortisone—ulcerative colitis	7.52e-05	0.00429	CcSEcCtD
Ergotamine—ADRA1A—lymphoid tissue—ulcerative colitis	7.38e-05	0.029	CbGeAlD
Ergotamine—Asthenia—Betamethasone—ulcerative colitis	7.25e-05	0.00414	CcSEcCtD
Ergotamine—Asthenia—Dexamethasone—ulcerative colitis	7.25e-05	0.00414	CcSEcCtD
Ergotamine—Nausea—Prednisolone—ulcerative colitis	7.2e-05	0.00411	CcSEcCtD
Ergotamine—Pruritus—Betamethasone—ulcerative colitis	7.15e-05	0.00408	CcSEcCtD
Ergotamine—Pruritus—Dexamethasone—ulcerative colitis	7.15e-05	0.00408	CcSEcCtD
Ergotamine—Vomiting—Triamcinolone—ulcerative colitis	7.08e-05	0.00404	CcSEcCtD
Ergotamine—Vomiting—Methylprednisolone—ulcerative colitis	7.07e-05	0.00403	CcSEcCtD
Ergotamine—Nausea—Hydrocortisone—ulcerative colitis	7.03e-05	0.00401	CcSEcCtD
Ergotamine—Nausea—Triamcinolone—ulcerative colitis	6.62e-05	0.00378	CcSEcCtD
Ergotamine—Nausea—Methylprednisolone—ulcerative colitis	6.6e-05	0.00377	CcSEcCtD
Ergotamine—Vomiting—Dexamethasone—ulcerative colitis	6.43e-05	0.00367	CcSEcCtD
Ergotamine—Vomiting—Betamethasone—ulcerative colitis	6.43e-05	0.00367	CcSEcCtD
Ergotamine—Asthenia—Prednisone—ulcerative colitis	6.32e-05	0.0036	CcSEcCtD
Ergotamine—Pruritus—Prednisone—ulcerative colitis	6.23e-05	0.00355	CcSEcCtD
Ergotamine—HTR2A—epithelium—ulcerative colitis	6.19e-05	0.0243	CbGeAlD
Ergotamine—CYP1A2—digestive system—ulcerative colitis	6.03e-05	0.0237	CbGeAlD
Ergotamine—Nausea—Betamethasone—ulcerative colitis	6e-05	0.00343	CcSEcCtD
Ergotamine—Nausea—Dexamethasone—ulcerative colitis	6e-05	0.00343	CcSEcCtD
Ergotamine—HTR2A—smooth muscle tissue—ulcerative colitis	5.97e-05	0.0234	CbGeAlD
Ergotamine—Vomiting—Prednisone—ulcerative colitis	5.6e-05	0.00319	CcSEcCtD
Ergotamine—ADRA1A—liver—ulcerative colitis	5.43e-05	0.0213	CbGeAlD
Ergotamine—Nausea—Prednisone—ulcerative colitis	5.23e-05	0.00298	CcSEcCtD
Ergotamine—HTR2A—digestive system—ulcerative colitis	4.71e-05	0.0185	CbGeAlD
Ergotamine—CYP1A2—liver—ulcerative colitis	4.49e-05	0.0176	CbGeAlD
Ergotamine—CYP3A4—digestive system—ulcerative colitis	4.36e-05	0.0171	CbGeAlD
Ergotamine—ABCB1—epithelium—ulcerative colitis	4.06e-05	0.0159	CbGeAlD
Ergotamine—HTR2A—liver—ulcerative colitis	3.51e-05	0.0138	CbGeAlD
Ergotamine—CYP3A4—liver—ulcerative colitis	3.25e-05	0.0128	CbGeAlD
Ergotamine—ABCB1—lymphoid tissue—ulcerative colitis	3.13e-05	0.0123	CbGeAlD
Ergotamine—ABCB1—digestive system—ulcerative colitis	3.09e-05	0.0121	CbGeAlD
Ergotamine—ABCB1—liver—ulcerative colitis	2.3e-05	0.00904	CbGeAlD
Ergotamine—ADRA1D—GPCR downstream signaling—IL2—ulcerative colitis	9.47e-06	0.00014	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—JAK2—ulcerative colitis	9.46e-06	0.00014	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—JAK2—ulcerative colitis	9.41e-06	0.00014	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	9.35e-06	0.000139	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—ADCY5—ulcerative colitis	9.34e-06	0.000139	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IL2—ulcerative colitis	9.28e-06	0.000138	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—IL2—ulcerative colitis	9.24e-06	0.000137	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—IL6—ulcerative colitis	9.23e-06	0.000137	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CXCL8—ulcerative colitis	9.16e-06	0.000136	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ADRB2—ulcerative colitis	9.13e-06	0.000135	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	9.11e-06	0.000135	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—JAK2—ulcerative colitis	9.01e-06	0.000134	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—CXCL8—ulcerative colitis	9e-06	0.000133	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—CXCL8—ulcerative colitis	8.95e-06	0.000133	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—JAK2—ulcerative colitis	8.9e-06	0.000132	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	8.82e-06	0.000131	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—MMP9—ulcerative colitis	8.78e-06	0.00013	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL2—ulcerative colitis	8.76e-06	0.00013	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—IL6—ulcerative colitis	8.71e-06	0.000129	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—NFKB1—ulcerative colitis	8.69e-06	0.000129	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	8.69e-06	0.000129	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—TP53—ulcerative colitis	8.69e-06	0.000129	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—CXCL8—ulcerative colitis	8.64e-06	0.000128	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL2—ulcerative colitis	8.6e-06	0.000128	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—JAK2—ulcerative colitis	8.59e-06	0.000127	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—CXCL8—ulcerative colitis	8.59e-06	0.000127	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—IL2—ulcerative colitis	8.55e-06	0.000127	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—JAK2—ulcerative colitis	8.55e-06	0.000127	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—ADCY5—ulcerative colitis	8.43e-06	0.000125	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ADRB2—ulcerative colitis	8.42e-06	0.000125	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—JAK2—ulcerative colitis	8.31e-06	0.000123	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—MMP9—ulcerative colitis	8.29e-06	0.000123	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ADRB2—ulcerative colitis	8.29e-06	0.000123	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—IL2—ulcerative colitis	8.25e-06	0.000122	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	8.22e-06	0.000122	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—IL2—ulcerative colitis	8.21e-06	0.000122	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ABCB1—ulcerative colitis	8.2e-06	0.000122	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—NFKB1—ulcerative colitis	8.2e-06	0.000122	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	8.18e-06	0.000121	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—JAK2—ulcerative colitis	8.17e-06	0.000121	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—ADCY5—ulcerative colitis	8.14e-06	0.000121	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—CXCL8—ulcerative colitis	8.12e-06	0.000121	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	8.11e-06	0.00012	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS1—ulcerative colitis	8.1e-06	0.00012	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—ADCY5—ulcerative colitis	8.1e-06	0.00012	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	8.01e-06	0.000119	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	8e-06	0.000119	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	7.86e-06	0.000117	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—CXCL8—ulcerative colitis	7.84e-06	0.000116	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—STAT3—ulcerative colitis	7.81e-06	0.000116	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—CXCL8—ulcerative colitis	7.8e-06	0.000116	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL2—ulcerative colitis	7.76e-06	0.000115	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	7.75e-06	0.000115	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ADCY5—ulcerative colitis	7.65e-06	0.000114	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—CXCL8—ulcerative colitis	7.58e-06	0.000112	CbGpPWpGaD
Ergotamine—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.58e-06	0.000112	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—JAK2—ulcerative colitis	7.54e-06	0.000112	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	7.54e-06	0.000112	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL2—ulcerative colitis	7.49e-06	0.000111	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	7.47e-06	0.000111	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—CXCL8—ulcerative colitis	7.46e-06	0.000111	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL2—ulcerative colitis	7.46e-06	0.000111	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	7.44e-06	0.00011	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—JAK2—ulcerative colitis	7.42e-06	0.00011	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—STAT3—ulcerative colitis	7.37e-06	0.000109	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	7.3e-06	0.000108	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CALM3—ulcerative colitis	7.29e-06	0.000108	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	7.27e-06	0.000108	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—IL2—ulcerative colitis	7.25e-06	0.000107	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TGFB1—ulcerative colitis	7.24e-06	0.000107	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ADCY5—ulcerative colitis	7.15e-06	0.000106	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	7.14e-06	0.000106	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—IL2—ulcerative colitis	7.13e-06	0.000106	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.07e-06	0.000105	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ADCY5—ulcerative colitis	7.03e-06	0.000104	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	6.98e-06	0.000104	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	6.89e-06	0.000102	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—CXCL8—ulcerative colitis	6.89e-06	0.000102	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TGFB1—ulcerative colitis	6.83e-06	0.000101	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—JAK2—ulcerative colitis	6.8e-06	0.000101	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	6.79e-06	0.000101	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—CXCL8—ulcerative colitis	6.77e-06	0.0001	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	6.75e-06	0.0001	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—JAK2—ulcerative colitis	6.66e-06	9.88e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	6.63e-06	9.84e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TP53—ulcerative colitis	6.59e-06	9.78e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—RELA—ulcerative colitis	6.59e-06	9.78e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL2—ulcerative colitis	6.58e-06	9.76e-05	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	6.49e-06	9.62e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL2—ulcerative colitis	6.47e-06	9.6e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS1—ulcerative colitis	6.47e-06	9.59e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—RELA—ulcerative colitis	6.45e-06	9.57e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	6.4e-06	9.49e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.36e-06	9.44e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	6.34e-06	9.4e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—JAK2—ulcerative colitis	6.26e-06	9.28e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CXCL8—ulcerative colitis	6.21e-06	9.21e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	6.16e-06	9.14e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CXCL8—ulcerative colitis	6.08e-06	9.02e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—RELA—ulcerative colitis	6.06e-06	8.99e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TP53—ulcerative colitis	5.96e-06	8.84e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL2—ulcerative colitis	5.94e-06	8.8e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—IL6—ulcerative colitis	5.91e-06	8.76e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	5.89e-06	8.74e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—JAK2—ulcerative colitis	5.82e-06	8.64e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CALM3—ulcerative colitis	5.82e-06	8.64e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL2—ulcerative colitis	5.81e-06	8.62e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—IL6—ulcerative colitis	5.78e-06	8.58e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CXCL8—ulcerative colitis	5.71e-06	8.47e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PPARG—ulcerative colitis	5.71e-06	8.47e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—RELA—ulcerative colitis	5.64e-06	8.37e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TP53—ulcerative colitis	5.62e-06	8.34e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MMP9—ulcerative colitis	5.62e-06	8.33e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.57e-06	8.26e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—NFKB1—ulcerative colitis	5.56e-06	8.24e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MMP9—ulcerative colitis	5.5e-06	8.16e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL2—ulcerative colitis	5.46e-06	8.1e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IL6—ulcerative colitis	5.46e-06	8.09e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—NFKB1—ulcerative colitis	5.44e-06	8.07e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—IL6—ulcerative colitis	5.43e-06	8.06e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CXCL8—ulcerative colitis	5.32e-06	7.88e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ADCY5—ulcerative colitis	5.29e-06	7.85e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—JAK2—ulcerative colitis	5.26e-06	7.8e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MMP9—ulcerative colitis	5.17e-06	7.66e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL6—ulcerative colitis	5.15e-06	7.63e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ALB—ulcerative colitis	5.13e-06	7.61e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NFKB1—ulcerative colitis	5.11e-06	7.58e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—RELA—ulcerative colitis	5.09e-06	7.55e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL2—ulcerative colitis	5.08e-06	7.54e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—JAK2—ulcerative colitis	5.08e-06	7.53e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL6—ulcerative colitis	5.05e-06	7.5e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—JAK2—ulcerative colitis	5.05e-06	7.49e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—STAT3—ulcerative colitis	4.99e-06	7.41e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS1—ulcerative colitis	4.99e-06	7.4e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—RELA—ulcerative colitis	4.92e-06	7.29e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—STAT3—ulcerative colitis	4.89e-06	7.25e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—RELA—ulcerative colitis	4.89e-06	7.25e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	4.83e-06	7.17e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MMP9—ulcerative colitis	4.81e-06	7.13e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CXCL8—ulcerative colitis	4.8e-06	7.12e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NFKB1—ulcerative colitis	4.76e-06	7.06e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	4.68e-06	6.94e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CXCL8—ulcerative colitis	4.63e-06	6.87e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFB1—ulcerative colitis	4.63e-06	6.87e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CXCL8—ulcerative colitis	4.61e-06	6.84e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—STAT3—ulcerative colitis	4.59e-06	6.81e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL2—ulcerative colitis	4.59e-06	6.8e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL6—ulcerative colitis	4.56e-06	6.77e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFB1—ulcerative colitis	4.53e-06	6.72e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ABCB1—ulcerative colitis	4.53e-06	6.72e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CALM3—ulcerative colitis	4.49e-06	6.67e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTGS2—ulcerative colitis	4.49e-06	6.66e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—JAK2—ulcerative colitis	4.46e-06	6.61e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL2—ulcerative colitis	4.43e-06	6.57e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	4.41e-06	6.54e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL6—ulcerative colitis	4.41e-06	6.53e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL2—ulcerative colitis	4.4e-06	6.53e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	4.38e-06	6.5e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL6—ulcerative colitis	4.38e-06	6.5e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MMP9—ulcerative colitis	4.34e-06	6.44e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RELA—ulcerative colitis	4.32e-06	6.4e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NFKB1—ulcerative colitis	4.29e-06	6.37e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	4.29e-06	6.37e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—STAT3—ulcerative colitis	4.27e-06	6.34e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFB1—ulcerative colitis	4.26e-06	6.32e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RELA—ulcerative colitis	4.25e-06	6.3e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ADCY5—ulcerative colitis	4.22e-06	6.27e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	4.22e-06	6.25e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	4.2e-06	6.22e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MMP9—ulcerative colitis	4.19e-06	6.22e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MMP9—ulcerative colitis	4.17e-06	6.18e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	4.16e-06	6.17e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NFKB1—ulcerative colitis	4.15e-06	6.15e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NFKB1—ulcerative colitis	4.12e-06	6.12e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CXCL8—ulcerative colitis	4.07e-06	6.03e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	4e-06	5.94e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	3.99e-06	5.92e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	3.99e-06	5.92e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFB1—ulcerative colitis	3.96e-06	5.88e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	3.95e-06	5.86e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PPARG—ulcerative colitis	3.95e-06	5.85e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	3.92e-06	5.81e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL2—ulcerative colitis	3.89e-06	5.77e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL6—ulcerative colitis	3.87e-06	5.74e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	3.86e-06	5.73e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—STAT3—ulcerative colitis	3.86e-06	5.72e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL2—ulcerative colitis	3.82e-06	5.67e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TP53—ulcerative colitis	3.81e-06	5.65e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	3.81e-06	5.65e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	3.74e-06	5.56e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TP53—ulcerative colitis	3.73e-06	5.54e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	3.73e-06	5.53e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—STAT3—ulcerative colitis	3.73e-06	5.53e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—STAT3—ulcerative colitis	3.71e-06	5.5e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MMP9—ulcerative colitis	3.68e-06	5.46e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	3.64e-06	5.4e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NFKB1—ulcerative colitis	3.64e-06	5.4e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	3.62e-06	5.37e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	3.58e-06	5.31e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFB1—ulcerative colitis	3.58e-06	5.31e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ALB—ulcerative colitis	3.55e-06	5.26e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	3.55e-06	5.26e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	3.54e-06	5.26e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	3.51e-06	5.2e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TP53—ulcerative colitis	3.51e-06	5.2e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ABCB1—ulcerative colitis	3.49e-06	5.18e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL6—ulcerative colitis	3.49e-06	5.18e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	3.48e-06	5.16e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	3.46e-06	5.14e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFB1—ulcerative colitis	3.45e-06	5.12e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFB1—ulcerative colitis	3.44e-06	5.1e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL6—ulcerative colitis	3.42e-06	5.07e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	3.29e-06	4.89e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	3.29e-06	4.88e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—STAT3—ulcerative colitis	3.27e-06	4.85e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TP53—ulcerative colitis	3.26e-06	4.84e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ADCY5—ulcerative colitis	3.26e-06	4.84e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	3.26e-06	4.83e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	3.22e-06	4.77e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL6—ulcerative colitis	3.21e-06	4.76e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	3.15e-06	4.67e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARG—ulcerative colitis	3.15e-06	4.67e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.1e-06	4.61e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFB1—ulcerative colitis	3.03e-06	4.5e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6—ulcerative colitis	2.99e-06	4.43e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	2.98e-06	4.43e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TP53—ulcerative colitis	2.94e-06	4.37e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	2.93e-06	4.34e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	2.92e-06	4.33e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TP53—ulcerative colitis	2.84e-06	4.22e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ALB—ulcerative colitis	2.83e-06	4.2e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TP53—ulcerative colitis	2.83e-06	4.2e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	2.71e-06	4.03e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	2.71e-06	4.02e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6—ulcerative colitis	2.7e-06	4e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6—ulcerative colitis	2.6e-06	3.86e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6—ulcerative colitis	2.59e-06	3.84e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TP53—ulcerative colitis	2.5e-06	3.7e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS2—ulcerative colitis	2.48e-06	3.68e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	2.48e-06	3.68e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TP53—ulcerative colitis	2.46e-06	3.64e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.43e-06	3.61e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	2.4e-06	3.57e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6—ulcerative colitis	2.28e-06	3.39e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6—ulcerative colitis	2.25e-06	3.33e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	2.23e-06	3.31e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	2.2e-06	3.27e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ALB—ulcerative colitis	2.19e-06	3.24e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	2.05e-06	3.03e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.91e-06	2.84e-05	CbGpPWpGaD
